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Abstract 
Background: Adherence and CD4 cell count change measure the progression of the disease in HIV patients after 
the commencement of HAART. Lack of information about associated factors on adherence to HAART and CD4 cell 
count reduction is a challenge for the improvement of cells in HIV positive adults. The main objective of adopting 
joint modeling was to compare separate and joint models of longitudinal repeated measures in identifying long-term 
predictors of the two longitudinal outcomes: CD4 cell count and adherence to HAART.
Methods: A longitudinal retrospective cohort study was conducted to examine the joint predictors of CD4 cell 
count change and adherence to HAART among HIV adult patients enrolled in the first 10 months of the year 2008 
and followed-up to June 2012. Joint model was employed to determine joint predictors of two longitudinal response 
variables over time. Furthermore, the generalized linear mixed effect model had been used for specification of the 
marginal distribution, conditional to correlated random effect.
Results: A total of 792 adult HIV patients were studied to analyze the longitudinal joint model study. The result from 
this investigation revealed that age, weight, baseline CD4 cell count, ownership of cell phone, visiting times, marital 
status, residence area and level of disclosure of the disease to family members had significantly affected both out-
comes. From the two-way interactions, time * owner of cell phone, time * sex, age * sex, age * level of education as 
well as time * level of education were significant for CD4 cell count change in the longitudinal data analysis. The mul-
tivariate joint model with linear predictor indicates that CD4 cell count change was positively correlated (p ≤ 0.0001) 
with adherence to HAART. Hence, as adherence to HAART increased, CD4 cell count also increased; and those patients 
who had significant CD4 cell count change at each visiting time had been encouraged to be good adherents.
Conclusion: Joint model analysis was more parsimonious as compared to separate analysis, as it reduces type I error 
and subject-specific analysis improved its model fit. The joint model operates multivariate analysis simultaneously; 
and it has great power in parameter estimation. Developing joint model helps validate the observed correlation 
between the outcomes that have emerged from the association of intercepts. There should be a special attention 
and intervention for HIV positive adults, especially for those who had poor adherence and with low CD4 cell count 
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Background
Sub-Saharan Africa has the most serious HIV and AIDs 
epidemic in the world. In 2013, approximately 24.7 mil-
lion people were living with HIV, accounting for 71% of 
the global total. In the same year, there were around 1.5 
million new HIV infections and 1.1 million AIDs-related 
deaths. The 2013 report indicates that, in sub-Saharan Afri-
can countries, the prevalence rate among both female and 
male sex workers was still high (13%) [1]. Ethiopia, as one 
of these countries has been affected by the epidemic with 
a prevalence of 1.5% [2]. Its burden has been high in the 
Amhara Region, including the catchment area of Felege 
Hiwot Teaching and Specialized Hospital [3]. Because of 
its large population size, the Amhara region has the largest 
Prevalence of human immunodeficiency virus [3]. Although 
the HIV prevalence shows a decreasing rate, still it bears 
a significant proportion of the epidemic burden as com-
pared to the national and worldwide encumbrance [4]. HIV 
affects the CD4 cell count in the human body, so it can be 
employed to make appropriate decisions for the initiation 
of HAART and proper management of the progression of 
the infection [5, 6]. Patients’ CD4 cell count should recover/
rebound/at least to the lower limit of the CD4 cell count for 
the general healthy adult population (500 cells/mm3), which, 
otherwise, can be an indication of immunologic failure [7].
In addition to HIV, there are also other factors affecting 
CD4 cell count changes. Some of these are demographic 
variables such as age (older ages are predictors of lower 
count response to HAART) [7, 8], sex (females experi-
ence better CD4 count response to HAART compared to 
males) [9, 10], and residence area (rural patients who start 
ART with a deteriorated CD4 cell count at the initiation of 
HAART poorly respond to HAART [11]. Previous studies 
also indicate that WHO’s clinical stage is an independent 
predictor of CD4 cell count at enrolment [12]. Other inves-
tigators state that there is a positive association between 
baseline CD4 cell count and its size after initiation of treat-
ment [13, 14]; however, this result was inconsistent with 
the result of other studies [8]. Identifying factors which 
influence the level of CD4 cell count other than HAART 
helps health professionals and patients to facilitate proper 
management and monitoring of health care interventions 
to be effective. Moreover, it helps check whether or not 
HIV patients who initiate HAART with baseline CD4 cell 
count ≤200 cells/mm3 recover to the normal range of CD4 
cell count after commencement of HAART [7].
On the other hand, the principal factors associated with 
non-adherence appear to be patient-related factors includ-
ing substance and alcohol abuse [15]. However, other 
factors such as inconvenient dosing frequency, dietary 
restrictions, pill burden and side-effects, poor patient–
care service provider relationships and poor care service 
provision may also contribute to the failure of adherence 
[16]. Another study disclosed that different factors such as 
sex, residence area, and ownership of cell phone contrib-
uted to patents’ irregular use of medications [17]. Another 
investigation indicated that patients’ current substance 
use concerning HAART, their beliefs about the necessity 
of HAART, and their trust in the HIV care provider are 
determinants for their non-adherence [18].
In HAART treatment, the number of CD4 cell count 
and adherence to HAART are measured repeatedly 
over time [15]. Patients’ improvement of adherence to 
HAART provides progression of CD4 cell count in the 
blood of HIV patients; and this increment of CD4 cell 
count at every visiting time encourages the patient to be a 
good adherent to HAART [19]. Hence, the above findings 
indicated that there are discrepancies among the findings 
of different studies. This discrepancy of findings suggests 
that identifying and overcoming the factors that reduce 
adherence to antiretroviral agents is of utmost impor-
tance for prolonged CD4 cell count progression and viral 
load suppression [15].
A number of key issues are raised in the study of adher-
ence to antiretroviral therapy and CD4 cell count change, 
determinants that affect jointly, and the development 
of interventions. Addressing these issues may provide 
valuable information about which patients are most at 
risk for non-adherence and about how adherence can 
be improved. It is well known that non-adherence in the 
treatment of HIV compromises the effectiveness of ther-
apy or progression of CD4 cell count change [20].
In many practical situations, we observed two or more 
longitudinal outcomes that need joint modeling of the 
response variables to identify predictors that affected 
jointly. Joint models are used to describe the joint behav-
ior of the two response variables simultaneously. These 
responses may have varied characteristics; that is, they 
might be binary, ordinal or continuous in nature.
Many previous studies had employed joint models of 
longitudinal outcomes and time to event [21–24]. Many 
of these methods were used for the joint modeling of 
change. The intervention may be important for pre-treatment counseling and awareness creation. The study also 
identified a group of patients who were with maximum risk of CD4 cell count change. It is suggested that this group 
of patients needs high intervention for counseling.
Keywords: HAART, Multivariate longitudinal data, Joint model, Adherence, CD4 cell count change
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longitudinal data and survival process outcomes, which 
have typically allowed a univariate outcome and a soli-
tary event time. These studies did not consider two lon-
gitudinal values observed repeatedly from the same 
subject and lacked multivariate analysis of two repeatedly 
observed results. Joint modeling between two longitudi-
nal outcome variables has advantages in reducing type I 
error rates in multiple tests with repeated observation on 
the same subject and improves efficiency in estimating 
parameters [25]. Thus, the current study was conducted 
with the objective of reviewing Generalized Linear 
Mixed Model (GLMM) approach that can be extended 
for multivariate longitudinal data by assuming separate 
random effect on each outcome variable, and then com-
bining them by imposing a joint multivariate distribution 
on the random effect. This approach has an advantage of 
having additional correlation emerging from the longitu-
dinal data structure that can be modeled with the same 
frame-work, and compare the separate and joint models 
with respect to parameter estimation in longitudinal data 
analysis. To the best of our knowledge, no other study has 
been conducted to assess factors affecting jointly these 
two longitudinal inter-related outcomes (CD4 cell count 
& adherence to HAART) around the study area.
Methods and data analysis
Study design
A retrospective cohort study was conducted to assess 
joint predictors of CD4 cell count change and adherence 
to HAART among adult HAART users enrolled in the 
first 10  months of 2008 and followed-up to June 2012. 
Joint modeling between count and ordinal responses was 
conducted.
Study area and population
The study was conducted at Felege-Hiwot Teaching and 
Specialized Hospital located in North-western Ethiopia, 
Amhara Region. The population of the study included 
HIV positive adults who initiated HAART treatment at 
Felege-Hiwot Teaching and Specialized Hospital.
Sample size and sampling procedure
From the total HIV positive adults who started HAART 
in the hospital from September 2008 to June 2012, 792 
were selected using residence-based stratified random 
sampling technique. Patients with a minimum of 2 visits 
and a maximum of 23 visits were included in the study.
Data collection procedures
The study exclusively used secondary data. Therefore, a 
data extraction check-list was designed and used to adopt 
the routinely collected data. A baseline CD4 cell count 
data was identified and collected from the registration 
documents of HAART attendants. The first month 
adherence was also considered as covariate for longitudi-
nal joint study. Similarly, other characteristics like socio-
demographic variables, visiting times and clinical data 
were also collected from the registration documents of 
patients. The data were collected by health care service 
providers after they had been given adequate orientation 
about the variables included in the study.
Data structure, compilation and analysis strategy
Secondary data were entered and analyzed using SAS 
version 9.2 software. For the sample to be included in the 
study, CD4 cell count measurement just before the ini-
tiation of HAART was considered as a covariate so that 
there could be at least two visit responses after the initia-
tion of HAART for analysis.
Quality of data
The quality of the data was controlled by data controllers 
from ART section of the hospital. The controllers were 
taken intensive training by the Ministry of Health for 
different services. The data extraction tools and the vari-
ables included in the study were tested for consistency of 
understanding and the completeness of the data items on 
45 random samples. Necessary amendments were made 
on the final data collection sheet.
Variables included in the study
The longitudinal response variables for current study 
were CD4 cell count change and adherence to HAART. 
The two response variables are different in nature. CD4 
cell count change is defined as the difference between 
CD4 cells/mm3 in the current visiting time and CD4 
cells/mm3 in visiting times immediately prior to the cur-
rent response. Hence, Yij − Yij−1, where yij is CD4 cell 
count result for the current visit and Yij−1 is the CD4 
cell count for the visit immediately prior to current visit 
which is discrete or count response. On the other hand, 
the adherence data obtained from the hospital is catego-
rized as poor, fair and good adherence which is ordinal in 
nature, and measured with pills count. A patient is poor 
adherent if his/her performance is less than 85% of the 
prescribed medication; and he/she is a fair adherent if 
his/her performance is between 85 and 95% of the pre-
scribed medication. If a patient’s adherence performance 
is at least 95% of the prescribed medication, such patient 
is categorized as a good adherent. The trend of adherence 
to HAART was tested using Cochran–Armitage test.
On the other hand, the predictor variables for the two 
responses were age in years, sex (male, female), marital 
status (living with partner, living without partner), own-
ership of cell phone (yes, no), weight in kilogram, base-
line CD4 cell count in cells/mm3, disclosure of the disease 
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to families (yes, no), residence area (rural, urban),WHO 
stages (stage I, stage II, stage III, stage IV), level of 
income (low, middle, high) visiting times (1, 2,…, 23) and 
first month adherence to HAART (poor, fair, good).
The impact of dropouts on the analysis
Patients who defaulted from HAART treatment will 
develop drug resistant virus and ultimately results in 
treatment failure and high risk of illness and death 
because of destruction of CD4 cell count by HIV. Non-
adherence, therefore, reduces CD4 cell count; and this 
demands joint attention to maximally benefit from 
HAART. A logistic regression was conducted to assess 
whether or not missing values were affected by previous 
results; and this indicated that dropouts were independ-
ent of the previous outcomes (χ2
1
 =  0.2018, p =  0.654). 
Dropout patients did not have reasons attributable to 
their progression rate of their previous visits; there-
fore dropout trend was Missed Completely at Random 
(MCAR). The trend of missing observation was assessed 
using a logistic regression model. Missing data were han-
dled using multiple imputation technique.
A Chi square test of association and independent 
sampled t test were used for the comparison of baseline 
characteristics that will be included and excluded in the 
analysis for categorical and continuous variables, respec-
tively. In model selection, we considered all predictors in 
the model, and fitted each product term obtained from 
predictor variables one at a time. This is important to 
assess the interaction effects of predictors on the variable 
of interest. A generalized linear mixed regression model 
(Quasi–Poisson) analysis was conducted to assess sepa-
rate parametric estimation for the change of CD4 cell 
count [14]; and ordinal logistic regression was employed 
for separate data analysis of adherence to HAART [26]. 
The type of covariance structure and the magnitude of 
residual errors were also considered in model selection. 
In this regard, the model with the least within individual 
residual variability was selected.
Multivariate GLMM formulation of joint models
Since the specification of the joint distribution of the 
two responses is not straight forward, we can have two 
approaches for the formulation of joint multivariate 
models. The first approach is based on a conditioning 
argument that allows joint distribution to factor out in 
marginal and conditional component, where the con-
ditioning can be done either on discrete or continuous 
outcome (avoiding direct specification of joint modeling) 
with introduction of probit approach. This approach 
does not directly lead to marginal inference, and the cor-
relation between the two outcomes cannot be directly 
estimated. The second is direct formulation of joint 
modeling for both response variables with the introduc-
tion of Placket–Dale approach (Placket latent variable) 
assumption for modeling bivariate outcomes [27].
Instead of using a latent variable approach, one can 
directly specify the joint distribution for both outcomes 
through mixed model with specification of the marginal 
distribution, conditional on the correlated random effect. 
The generalized linear mixed model (GLMM) forms a 
very general class of subject-specific model which is used 
for univariate repeated measures. Joint model can be 
measured repeatedly over time or may be observed within 
a hierarchical trend. A GLMM can be easily adapted to 
situation where various outcomes are observed.
To obtain valid inferences, the joint model could 
account for the correction among the outcomes and 
effects of different factors. The joint generalized linear 
mixed model assumes that each outcome and the univar-
iate models are combined through specification of joint 
multivariate distribution for all random effects. Further-
more, the mixed model can be applied with specification 
of marginal distribution, which is conditional on corre-
lated random effect. To assess the association between 
CD4 cell count change and adherence to HAART for the 
data obtained at Felege-Hiwot Teaching and Specialized 
Hospital, the joint generalized linear mixed model was 
fitted. In this model, the correlation between the two 
responses is specified through the random effect struc-
ture assuming separate random intercept for each out-
come and combining them by imposing joint multivariate 
distribution on the random intercept.
Results
The baseline characteristics of patients included in the 
analysis indicates that the median age of patients was 
36  years old (IQR 28–48). Of all the patients studied 
50.6% were females, 40.1% were living in rural area, 55.2% 
were living without partners, 52.7% did not disclose the 
disease to family members living together and only 68.2% 
had good adherence in the first month treatment. Over 
50% of the patients had attended their secondary educa-
tion and over 50% of them had no cell phone. The aver-
age baseline CD4 cell count for all patients was 134 (IQR 
113–180) and the average CD4 cell count change for the 
first month was 15.9 cell/mm3 (IQR 8–26). The average 
CD4 cell count change at all visits varies from 15.9 cells/
mm3 at the 1st visit to 28 cells/mm3 at the 23rd visit. The 
corresponding standard deviations were 18 cells/mm3 
at the first visit and 27 cells/mm3 at the last visit of the 
study period. Hence, the distribution at each visit shows 
that there were over-dispersion (variance  >  mean), and 
over-dispersed count response regression models should 
be considered for marginal analysis of CD4 cell count 
change data.
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To fit the joint models of CD4 cell count change and 
adherence to HAART, first Quasi–Poisson for CD4 cell 
count change [14, 28] and ordinal logistic regression 
model for adherence to HAART data were considered 
separately [29]. Hence the parameter estimation for mar-
ginal models with log and cumulative logit link (Table 1) 
and conditional independence random-effect models 
(Table 2) were developed [30]. In addition, the parameter 
estimation for linear predictor or models which consist of 
the same variables already identified from GLMM mod-
els were developed (Table 3).
Table  1 indicates the separate or joint marginal mod-
els for CD4 cell count change and adherence to HAART 
using Quasi–Poisson regression and ordinal logistic 
regression. As indicated in the Table 1, age, weight, initial 
CD4 cell count and ownership of cell phone significantly 
affected both outcomes. From the two-way interaction, 
time *  level of education, time * sex, age * sex as well as 
age  *  level of education were significant for both out-
come variables. The separate models shown in Table  1 
were univariate distributions. Table 2, on the other hand, 
shows the combination of the separate models by impos-
ing joint multivariate distribution on the random effect. 
The analysis was done using generalized log likelihood 
function with Laplace approximation. The conditional 
independence of random-effect models considered in 
this analysis shows that the GLMM approach can be 
extended to multivariate longitudinal data by assuming 
separate random effect for each outcome and combining 
them by imposing a joint multivariate distribution on the 
random effects. The SAS procedure using general log-
likelihood function allows one to impose the joint mul-
tivariate distribution on the random effects from the two 
separate models. The results obtained from fitting a joint 
model for the two response variables of uncorrelated ran-
dom intercept using the GLIMMIX procedure were used 
as initial parameter estimates.
Table  2 shows the conditional independence random 
intercept model. As indicated in the Table 2, patients’ age, 
weight, initial CD4 cell count, visiting time, ownership of 
cell phone and sex were jointly and significantly associ-
ated with both response variables. The same sign in para-
metric estimation indicates that the two outcomes are 
positively correlated to each other. Since the conditional 
independence assumption might be too restrictive, we, 
therefore, attempted to relax the conditional independ-
ence assumption by re-fitting the joint random intercepts 
model with possible correlated errors. However, the con-
ditional independence approach, which we attempted, 
failed to converge the model. During this time, introduc-
ing conditional dependence of one response in terms 
of the other using linear predictor is important [31]. 
This approach is also helpful to validate the observed 
correlation between the two outcomes emerging from 
the association of the random intercepts. We fitted a gen-
eralized linear mixed model for CD4 cell count change as 
response variable including adherence to HAART in the 
linear predictor. The result is presented in Table 3 below. 
The result indicates that CD4 cell count change is posi-
tively correlated (p ≤ 0.0001) with adherence to HAART.
As shown in Table  3, age, weight, baseline CD4 cell 
count, visiting times, marital status, sex, residence area, 
ownership of cell phone, disclosure of the disease to 
family members and first month adherence have sig-
nificantly affected CD4 cell count change. Hence, as 
age of a patient increased by 1  year, the log of change 
of CD4 cell count decreased by 3.3% cell/mm3 keep-
ing the other variables constant [ARR = 0.0327, 95% CI 
(0.0098, 0.0899); p = 0.0264]. As the number of visiting 
times increased by one unit, the log of change of CD4 cell 
count increased by 2.4% [ARR = 1.0240, 95% CI (1.0206, 
1.0276); p < 0.0001]. The analysis revealed that the rate of 
change of CD4 cell count for patients without ownership 
of cell phone was 2.9% less as compared to patients with 
ownership of cell phone [ARR = 0.0290, 95% CI (0.0172, 
0.0870); p < 0.0001]. The log of change of CD4 cell count 
for patients with fair adherence at a given visiting time 
was 2.9% less than those patients who had good adher-
ence [ARR  =  0.0290133, 95% CI (0.00974, 0.043931); 
p < 0.0001] and the log of change of CD4 cell count for 
patients with poor adherence at visiting time, t was 5.7% 
less than those of good adherent patients [ARR = 0.0573, 
95% CI (0.0214, 0.0706); p  <  0.0001]. From the two 
way interaction effects; time  *  ownership of cell phone, 
time * sex, time * level of education, age * sex, age * level 
of education were significantly and jointly affected both 
responses through linear link (refer Table 3).
Interaction effects of ownership of cell phone and visiting 
times
For a unit increase of visiting time, the rate of change of 
CD4 cell count for patients without owner of cell phone 
was 5.2% less than patients with owner of cell phone 
[ARR = 0.0518, 95% CI (0.0443, 0.0996); p < 0.0001]. Fig-
ure 1 indicates that the log of change of CD4 cell count 
for patients with owner of cell phone was by far better 
than those patients without cell phone as visiting time 
increased.
Interaction effect between sex of patients and follow‑up 
visits
As visiting times of adult patients increased by one unit, 
the log of change of CD4 cell count for female patients 
was 0.3% greater than male patients [ARR = 1.0027, 95% 
CI (1.0016, 1.0038); p < 0.0001]. From Fig. 2, we saw that 
as visiting time increased, the log of change of CD4 cell 
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Table 1 Parameter estimates and corresponding standard errors of joint marginal model/separate analysis for CD4 cell 
count change data and adherence to HAART with un-structured working covariance
* Significant p values
Parameter CD4 cell count change Adherence to HAART
Estimate St. error p value Estimate St. error p value
Intercept 4.0066 0.0329 <0.0001 0.8921 0.2428 0.0002
Age −0.0002 0.0007 0.0264* −0.0111 0.0029 0.0001*
Weight −0.0006 0.0002 0.0020* 0.0158 0.0027 <0.0001*
Initial CD4 cell count 0.0048 0.0002 <0.0001* 0.0410 0.0013 <0.0001*
Time 0.0238 0.0017 <0.0001* −0.0429 0.0012 <0.0001*
Marital status (ref. = without part)
 Living with part 0.0064 0.0034 0.0464* −0.0241 0.0481 0.6156
Sex (ref. = male)
 Female −0.0131 0.0039 0.0009* −0.4548 0.1036 <0.0001*
Area (ref. = urban)
 Rural 0.0213 0.0105 0.0425* 0.1517 0.1029 0.1405
Education (ref. = tertiary)
 No education −0.0410 0.0059 <0.0001* −0.0970 0.1480 0.5123
 Primary education −0.0406 0.0065 <0.0001* 0.0970 0.1646 0.5555
 Secondary educ. −0.0577 0.0055 <0.0001* 0.1135 0.1423 0.4248
Level of income (ref. = high income)
 Middle income −0.0099 0.0054 0.0679 −0.1055 0.0772 0.1715
 Low income −0.0106 0.0041 0.0095* 0.1661 0.0572 0.0037*
Owner of cell phone (ref. = with phone)
 Without cell phone −0.0204 0.0038 <0.0001* 0.6957 0.0975 <0.0001*
Level of disclosed the disease (ref. = yes)
 No −0.0062 0.0034 0.0715 0.2834 0.0484 <0.0001*
WHO stages (ref. = stage IV)
 Stage I 0.1191 0.0077 <0.0001* −0.1978 0.1101 0.0725
 Stage II 0.1239 0.0064 <0.0001* 0.2195 0.0904 0.0152*
 Stage III 0.1006 0.0063 <0.0001* 0.1500 0.0886 0.0904
Time * ownership of cell phone (ref. = yes)
 Time * no −0.0099 0.0013 <0.0001* −0.0094 0.0077 0.2236
Time * area (ref. = urban)
 Time * rural −0.0024 0.0020 0.2192 0.0033 0.0082 0.2236
Time * sex (ref. = male)
 Time * female 0.0027 0.0006 <0.0001* 0.0226 0.0067 0.0007*
Time * education (ref. = tertiary)
 Time * no educ. 0.0062 0.0007 <0.0001* 0.0300 0.0114 0.0085*
 Time * primary educ. 0.0086 0.0008 <0.0001* 0.0315 0.0128 0.0138*
 Time * secondary educ. 0.0067 0.0007 <0.0001* 0.0376 0.0111 0.0007*
Age * sex (ref. = male)
 Age * female −0.0046 0.0004 <0.0001* 0.0078 0.0081 0.0345*
Age * education (ref. = tertiary)
 Age * no educ. −0.0045 0.0006 <0.0001* −0.0752 0.0098 <0.0001*
 Age * primary educ. −0.0022 0.0007 0.0015* −0.1197 0.0115 <0.0001*
 Age * secondary educ. −0.0036 0.0006 <0.0001* −0.0501 0.0102 <0.0001*
Age * area (ref. = urban)
Age * rural area −0.0025 0.0004 <0.0001* 0.0014 0.0065 0.8275
Mar. stat * level of exposedness (ref. = closed)
 Mar. stat * disclosed the disease 0.0067 0.0007 0.0652 0.2001 0.0989 0.0430*
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Table 2 Parameter estimates and corresponding standard errors for conditional independence random intercept model 
with CD4 cell count change data and adherence to HAART
* Significant p values
Parameter CD4 cell count change Adherence to HAART
Estimate St. error p value Estimate St. error p value
Intercept 4.0066 0.0329 <0.0001 0.8921 0.2428 0.0002*
Age −0.0002 0.0007 0.0264* −0.0111 0.0029 0.0001*
Weight −0.0006 0.0002 0.0020* 0.0158 0.0027 <0.0001*
Initial CD4 cell count 0.0048 0.0002 <0.0001* 0.0410 0.0013 <0.0001*
Time 0.0238 0.0017 <0.0001* 0.0129 0.0312 <0.0001*
Marital status (ref. = without part)
 Living with part 0.0064 0.0034 0.0464* −0.0241 0.0481 0.6156
Sex (ref. = male)
 Female −0.0131 0.0039 0.0009* −0.4548 0.1036 <0.0001*
Area (ref. = urban)
 Rural 0.0213 0.0105 0.0425* 0.1517 0.1029 0.1405
Education (ref. = tertiary)
 No education −0.0410 0.0059 <0.0001* −0.0970 0.1480 0.5123
 Primary education −0.0406 0.0065 <0.0001* 0.0970 0.1646 0.5555
 Secondary educ. −0.0577 0.0055 <0.0001* 0.1135 0.1423 0.4248
Level of income (ref. = high income)
 Middle income −0.0099 0.0054 0.0679 −0.1055 0.0772 0.1715
 Low income −0.0106 0.0041 0.0095* 0.1661 0.0572 0.0037*
Owner of cell phone (ref. = with phone)
 Without cell phone −0.0204 0.0038 <0.0001* 0.6957 0.0975 <0.0001*
Level of disclosure (ref. = disclosed)
 Closed the disease −0.0062 0.0034 0.0715 0.2834 0.0484 <0.0001*
WHO stages (ref. = stage IV)
 Stage I 0.1191 0.0077 <0.0001* −0.1978 0.1101 0.0725
 Stage II 0.1239 0.0064 <0.0001* 0.2195 0.0904 0.0152*
 Stage III 0.1006 0.0063 <0.0001* 0.1500 0.0886 0.0904
Time * ownership of cell phone (ref. = yes)
 Time * no −0.0099 0.0013 <0.0001* −0.0094 0.0077 0.0236*
Time * area (ref. = urban)
 Time * rural −0.0024 0.0020 0.2192 0.0033 0.0082 0.0236*
Time * sex (ref. = male)
 Time * female 0.0027 0.0006 <0.0001* 0.0226 0.0067 0.0007*
Time * education (ref. = tertiary)
 Time * no educ. 0.0062 0.0007 <0.0001* 0.0300 0.0114 0.0085*
 Time * primary educ. 0.0086 0.0008 <0.0001* 0.0315 0.0128 0.0138*
 Time * secondary educ. 0.0067 0.0007 <0.0001* 0.0376 0.0111 0.0007*
Age * sex (ref. = male)
 Age * female −0.0046 0.0004 <0.0001* 0.0078 0.0081 0.0345*
Age * education (ref. = tertiary)
 Age * no educ. −0.0045 0.0006 <0.0001* −0.0752 0.0098 <0.0001*
 Age * primary educ. −0.0022 0.0007 0.0015* −0.1197 0.0115 <0.0001*
 Age * secondary educ. −0.0036 0.0006 <0.0001* −0.0501 0.0102 <0.0001*
Age * area (ref. = urban)
 Age * rural area −0.0025 0.0004 <0.0001* 0.0014 0.0065 0.8275
Mar. stat * level of exposedness (ref. = closed)
 Marital stat * disclosed the disease 0.0067 0.0007 0.0652 0.2001 0.0989 0.0430*
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Table 3 Parameter estimates for joint model of CD4 cell count change data using linear predictor
* Significant at 5% level of confidence for joint model
Parameter Estimate St. error Adjusted rate ratio (ARR) Wald 95% CI p value
Intercept 4.0066 0.0029 54.9596 51.5318 58.6156 <0.0001
Age −3.4201 0.0001 0.0327 0.0098 0.0899 0.0264*
Weight 0.0036 0.0001 1.0036 0.0021 1.0045 0.0820
Baseline CD4 cell count 0.0048 0.0002 1.0048 1.0035 1.0061 <0.0001*
Time 0.0238 0.0007 1.0240 1.0206 1.0277 <0.0001*
Marital status (ref. = without part)
 Patients living with partner 0.0064 0.0014 1.0064 0.9998 1.0132 0.0564
Sex (ref. = male)
 Female 0.0131 0.0005 1.0132 0.0124 1.0155 0.0659
Area (ref. = urban)
 Rural −2.65 0.0005 0.0706 0.9558 1.0982 0.0525
Education (ref. = tertiary)
 No educ. −4.02 0.0019 0.0183 0.9487 1.0298 0.0627
 Primary educ. −3.45 0.0005 0.0317 0.9480 1.9725 0.0801
 Secondary educ. −2.86 0.0015 0.0573 0.9337 1.0481 0.0568
Level of income (ref. = high income)
 Middle income −4.12 0.0014 0.0162 0.9797 1.0007 0.0679
 Low income −3.63 0.0001 0.0265 0.9816 1.0974 0.0095
Owner of cell phone (ref. = yes)
 No −3.54 0.0018 0.0290 0.0172 0.0870 <0.0001*
First month adherence level (ref. = good adherence) 
 Fair adherence −3.54 0.0002 0.0290 0.0097 0.0439 <0.0001*
 Poor adherence −2.86 0.0091 0.0573 0.0214 0.0706 <0.0001*
Level of disclosed the disease (ref. = yes) 
 No −2.6 0.0014 0.0743 0.9871 1.0995 0.0715
WHO stages (ref. = stage IV)
 Stage I 0.1191 0.0007 1.1265 0.1097 1.1436 0.0651
 Stage II 0.1239 0.0014 1.1319 0.1173 1.0461 0.0612
 Stage III 0.1006 0.0023 1.1058 0.0923 1.0196 0.0851
Time * owner of cell phone (ref. = yes) 
 Time * no −2.96 0.0003 0.0518 0.0443 0.0996 <0.0001*
Time * area (ref. = urban) 
 Time * rural −2.4 0.0010 0.0907 0.9937 1.0004 0.0792
Time * sex (ref. = male)
 Time * female 0.0027 0.0002 1.0027 1.0016 1.0038 <0.0001*
Time * education (ref. = tertiary)
 Time * no educ. −4.00 0.0007 0.0183 0.0082 0.0452 <0.0001*
 Time * primary educ. −3.83 0.0002 0.0124 0.0044 0.0360 <0.0001*
 Time * secondary educ. −3.43 0.0001 0.0086 0.0053 0.0147 <0.0001*
Age * sex (ref. = male) 
 Age * female −3.421 0.0002 0.0326 0.0144 0.0662 <0.0001*
Age * education (ref. = tertiary) 
 Age * no educ. 0.042 0.0002 1.0433 1.0126 1.0799 <0.0001*
 Age * primary educ. 0.032 0.0001 1.0325 1.0112 1.0601 0.0015*
 Age * secondary educ. 0.023 0.0004 1.0232 1.0093 1.0594 <0.0001*
Age * area (ref. = urban) 
 Age * rural area 0.0025 0.0002 1.0025 0.0017 1.0034 0.08621
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count for female patients is greater than that of male 
patients.
Interaction effect between age and sex of patients
From Table  3, it is indicated that as age of patients 
increased by 1  year, the decreasing rate of change of 
CD4 cell count for female patients was 3.3% less than 
male patients [ARR  =  0.0326, 95% CI (0.0144, 0.0662); 
p  <  0.0001]. Hence, as age of patients increased, the 
decreasing rate for female patients was less probable as 
compared to male patients (refer to Fig. 3).
Interaction effect between level of education and visiting 
times
As visiting time of patients increased by one unit, the rate 
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Fig. 2 Interaction plot between sex of patients and their follow-ups
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was 1.8% less than those of tertiary educated patients 
[ARR  =  0.0183, 95% CI (0.0082, 0.0452); p  <  0.0001]. 
Similarly comparing primary educated patients with ter-
tiary level, the log of change of CD4 cell count for pri-
mary educated patients was 1.2% less than tertiary levels 
[ARR  =  0.0124, 95% CI (0.0044, 0.03662); p  <  0.0001] 
and the log of change of CD4 cell count for second-
ary educated patients was 0.8% less than tertiary edu-
cated patients [ARR =  0.0086, 95% CI (0.0053, 0.0147); 
p  <  0.0001] (refer to Table  3). Figure  4 indicates that as 
visiting time of patients increased, patients with tertiary 
education perform high log of CD4 cell count change as 
compared to the other group.
Interaction effect between level of education and age 
of patients
It is known from the literature that as age of patients 
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Fig. 4 Interaction plot between level of education and follow-up visits
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However, the decreasing rate for different level of edu-
cation was different from the current analysis. Hence 
as age of a patient increased by 1  year, the decreasing 
rate of CD4 cell count for non-educated patient was 
4.3% greater as compared to tertiary educated patients 
[ARR  =  1.0433, 95% CI (1.0126, 1.0799); p  <  0.0001]; 
the log of change CD4 cell count for primary educated 
patients was 3.2% greater than tertiary educated patients 
[ARR = 1.0325, 95% CI (1.0112, 1.0601); p = 0.0015]; and 
decreasing rate of CD4 cell count for secondary educated 
patients was 2.3% greater than tertiary educated patients 
[ARR  =  1.0232, 95% CI (1.0093, 0.0594); p  <  0.0001]. 
Figure  5 indicates that as age of patients increase, the 
decreasing rate of tertiary educated patients was lower 
than other groups.
Discussion
We have presented a general approach to the joint analy-
sis of two longitudinal response variables assuming their 
separate analysis. The results in this study indicated that 
the separate models which did not include patients’ spe-
cific effects were not significantly different from joint 
models developed with the assumption of separate analy-
sis. As indicated above the joint models were formed by 
imposing the joint multivariate distribution of random 
effect, Hence, the results of both separate and joint analy-
sis were consistent. However, the joint models were sim-
pler as compared to the separate models as their effective 
member of parameters was smaller. In other words, the 
reduction of the number of effective parameters ensures 
that joint models were more parsimonious/less com-
plex in parameter estimation of longitudinal data analy-
sis. This result complies with previous researches [30, 
32, 33]. Furthermore, joint models were advantageous 
for answering multivariate questions at the same time. 
They also helped assess the correlation between the two 
response variables and gave ample opportunity to see 
predictors of the two response variables jointly.
The result in this study indicated that CD4 cell count 
change and adherence to HAART had been influenced 
jointly by some of the covariates like age, weight, base-
line CD4 cell count, visiting times, sex, ownership of cell 
phone, first month adherence and level of disclosing the 
disease to family members and by their interaction effects 
(refer to Table 3). Recent findings from longitudinal study 
[34] also proved that CD4 cell count change was affected 
by many of these covariates. This finding suggests that 
the hospital should advise adult HIV patients to adhere 
the prescribed medication on time to achieve high CD4 
cell count change. Patients, who had cell phone, had 
more probability to adhere the prescribed medication 
than patients who had not. This result is supported by 
another study [17]. Hence alarm of cell phone/memory 
aids/can be used to remember patients the time for tak-
ing pills and visiting health institutions.
As ages of patients increase, CD4 cell count and adher-
ence to HAART decrease. But, the decreasing rate of these 
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Fig. 5 Interaction plot between level of education and age of patients
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less likely as compared to that of the others. This might 
occur because as patients become more educated, they 
may have better care of their health. This result has been 
supported by previous study [16]. Patients with high initial 
CD4 cell count adhere the prescribed medication more; 
and these results in high rate of change of CD4 cell count 
through time. This result suggests that patients should 
start their HAART without keeping the cut-off points 
(200 cell/mm3). This result is supported by previous study 
[35] on the impact of adherence on CD4 cell count change.
The two responses were higher for urban adult patients 
than rural areas through time. The reason for this might 
be the long distance of the rural areas from health insti-
tutions, and patients in these areas may come after high 
destruction of CD4 cells by HIV. There are discordant 
other findings concerning this. For instance, the result 
of this study agrees with a previous study [36]. However, 
another study indicates that rural patients’ adherence 
to HAART is better through time, and this implies that 
they have better CD4 cell count [37]. Therefore, this issue 
needs further investigation for reliable information.
Patients who lived with a partner had more probability 
to adhere the prescribed medication and had high CD4 
cell count change as compared to patients who lived 
without partners. This can be associated with lack of 
social support for patients living without partner. This 
result had been supported by former research [17]. The 
result of this study also indicates that female patients had 
more probability to adhere the prescribed medication 
than males, and through time they had achieved high 
rate of change of CD4 cell count. This result, however, is 
inconsistent with previous studies [38].
Limitations
The interactions between variables, which were not 
expected during the data collection process, were identi-
fied during data analysis. The cause for these interaction 
occurrences was not detected and explained. Adherence 
to HAART, which was one of the response variables, was 
measured in pill count technique. This technique had a 
disadvantage that include patients’ switching of medicines 
between bottles and discarding pills before visits [27]. 
Despite its limitations, pill count technique has strong 
linear relationship with viral load [39]. The result in this 
analysis is true only for adult patients; that is, it may have 
different outcomes when patients with all ages are consid-
ered. This could be a potential area for further investigation.
Conclusions
Longitudinal joint models fitted for the joint data analysis 
under this investigation. Generalized linear mixed model 
was extended to multivariate cases in the data analysis 
process. This had been done using marginal/separate 
analysis as well as conditional independent random 
effect models and a random intercept model with cor-
related residual error structure. Developing joint models 
has helped validate the observed correlation between the 
outcomes emerging from the association of intercepts. 
The result under this investigation indicated that some 
covariates were significantly associated with the change 
of CD4 cell count; and the development of joint model 
for the two responses gave powerful estimation as com-
pared to the separate or marginal model. The result of 
this study identified a certain group of patients who were 
with maximum risk of CD4 cell count change, but who 
had poor adherence performance. This group of patients 
needs high intervention in counseling and awareness 
creation.
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